Apexigen Company
Apexigen is a biopharmaceutical product development company developing products to address life-threatening and difficult to treat diseases.
Industry:
PharmTech
Investment Stage:
N/A
Investors Number:
10
Technology:
Data-driven Technologies
Last Funding Type:
Series C
Headquarters:
Burlingame, California, United States
Founded Date:
2010
Investor Type:
N/A
Funding Status:
Late Stage Venture
Total Funding:
$158M
Estimated Revenue:
$1M to $10M
Number Of Exists:
N/A
Employee Number:
11-50